Amsterdam, the Netherlands - 12 February 2018 - LSP announces its investment in Simplify Medical. The LSP Health Economics Fund 2 (LSP HEF 2) leads the second tranche of the company’s Series B financing of $23.5 million, completing the oversubscribed round totaling $44.25 million. Simplify Medical is focused on cervical spinal disc arthroplasty, using innovative, MRI-friendly materials designed to decrease the need for ionizing radiation and enhance patient options. The Simplify Disc has received the CE Mark and is commercially available in selected European markets. Early clinical data has shown substantial improvement in patient pain scores and functional improvement after treatment.
Fouad Azzam, LSP General Partner, will represent LSP HEF 2 on the board, with René Kuijten, LSP Managing Partner, joining the board to represent the LSP 5 fund, which led the first tranche of this investment round.
A link to the company's press release can be found here.
About Simplify Medical
Simplify Medical is focused on cervical spinal disc arthroplasty, using innovative, MRI-friendly materials designed to decrease the need for ionizing radiation and enhance patient options. Simplify Medical is located in Sunnyvale, California. To learn more, visit www.simplifymedical.com/.
LSP (Life Sciences Partners) is an independent European investment firm, providing financing for private and public life sciences companies. LSP’s mission is to connect investors to inventors, focusing on unmet medical needs. With over €1.3 billion ($1.5 billion) of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s leading life sciences investors. In 2017, LSP launched LSP HEF 2 with a fund volume of €280 million targeting investment opportunities in private medical technology companies which offer products that can both improve the quality of patient care and lower healthcare spending. To learn more, visit www.lspvc.com.
Dr F. Azzam
General Partner LSP« back to overview